Company intelligence / Profile preview

Ferment Consortium

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Ferment Consortium is a $350 million company-creation and investment vehicle associated with Ginkgo Bioworks that founds and funds synthetic biology companies across multiple industries, including health, nutrition, herbal medicines and animal health; it does not itself run therapeutic programs or clinical trials but enables portfolio companies that may do so[1][3][4][6][7].

Industry: Investors

Partnerships

Ginkgo Bioworks[3][4][6][7][8]Viking Global Investors[3][4][8]General Atlantic[3][4][5][8]Cascade Investment[3][4][5][6][7][8]

Beyond the preview

Go deeper on Ferment Consortium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferment Consortium.

Explore the full profile